ROJUZDA
Swiss trademark · 678464 · Word mark · In force
Register entry
- Registration number
- 678464
- Application number
- 58198/2015
- Status
- In force
- Type
- Word mark
- Filed
- Jul 9, 2015
- Registered
- Sep 29, 2015
- Published
- Sep 29, 2015
- Protected until
- Jul 9, 2035
- Source
- Swissreg
Goods and services
Pharmaceuticals
Préparations pharmaceutiques pour usage dans les domaines de l'oncologie, de l'immunologie et de l'inflammation; préparations pharmaceutiques pour usage dans le traitement des syndromes bêta-thalassémiques et myélodisplastiques, de maladies auto inflammatoires, de maladies auto-immunes, de maladies du sang, de cancers, de l'arthrite, de maladies musculo-squelettiques et de maladies de la peau; préparations pharmaceutiques, notamment médicaments inhibiteurs de cytokines; préparations pharmaceutiques destinées à moduler le système immunitaire.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 3, 2025
Renewed
- Expiry date
- 09.07.2025 → 09.07.2035
Published in Swissreg on 03.06.2025
- Feb 5, 2025
Holder’s address changed
- Owner
- Celgene Corporation, 86 Morris Avenue, Summit (NJ 07901), USA → Celgene Corporation, Route 206 & Province Line Road, Princeton, New Jersey 08543, USA
Published in Swissreg on 05.02.2025
- Jun 22, 2021
Agent removed
- Representative
- Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)
Published in Swissreg on 22.06.2021
- Jun 22, 2021
Agent entered
- Representative
- Troller Hitz Troller, Rechtsanwälte, Schweizerhofquai 2, Postfach, 6002 Luzern
Published in Swissreg on 22.06.2021
- Sep 29, 2015
Registered
Published in Swissreg on 29.09.2015
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.